2023 annual financial data
BridgeBio Pharma 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was -5,672.58%.
Operating income was -607,370,000 USD and net income was -643,202,000 USD.
Operating cash flow was -527,720,000 USD.
Get free BridgeBio Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,303,000 USD
- Operating income
- -607,370,000 USD
- Net income
- -643,202,000 USD
- Operating cash flow
- -527,720,000 USD